F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
August 31, 2017 ・0 comments ・Topic： trending Upcoming
F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
The Food and Drug Administration on Wednesday approved the first-ever treatment that genetically alters a patient’s own cells to fight cancer, a milestone that is expected to transform treatment in the coming years.
August 31, 2017 at 12:20PM
via atn http://ift.tt/2x8te86
Post a Comment
WE LOVE TO HEAR YOUR COMMENTS
If you can't commemt, try using Chrome instead.